FIGURE

Fig. S2

ID

ZDB-FIG-101119-24

Publication

Cao et al., 2009 - Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models

Other Figures

Fig. 1
Fig. 2
Fig. 4
Fig. S1
Fig. S2
Fig. S3
Fig. S4
Fig. S6

All Figure Page

Back to All Figure Page

Fig. S2

Treatment of TSA causes ventral body curvature in a dosage dependent manner. (A) Embryos were treated with DMSO, 100, and 200 nM TSA from the 30% epiboly stage. (B) pkd2/hi4166 mutant embryos on 2 dpf treated with 200 nM TSA from 27 hpf, compared with embryos treated with DMSO (Fig. 1C) and 500 nM TSA (Fig. 1D).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Proc. Natl. Acad. Sci. USA